This is a multicenter, prospective, observational cohort registry in subjects receiving myelosuppressive chemotherapy for a non-myeloid malignancy who are considered to be at high risk for developing febrile neutropenia (FN).

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

A Prospective Observational Registry Study for Real-World Outcome Analysis to Estimate the Incidence of FN Among Subjects Who Are at High Risk for FN, Have Non-myeloid Malignancies, and Are Receiving Udenyca for Prophylaxis of FN

Treatment Trials

Focus your search

An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca

Description

Conditions